CA2599712C - Folic acid-, vitamin b6- and vitamin b12-containing agents and the use thereof - Google Patents

Folic acid-, vitamin b6- and vitamin b12-containing agents and the use thereof Download PDF

Info

Publication number
CA2599712C
CA2599712C CA2599712A CA2599712A CA2599712C CA 2599712 C CA2599712 C CA 2599712C CA 2599712 A CA2599712 A CA 2599712A CA 2599712 A CA2599712 A CA 2599712A CA 2599712 C CA2599712 C CA 2599712C
Authority
CA
Canada
Prior art keywords
vitamin
folic acid
weight
quantitative
physiologically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2599712A
Other languages
English (en)
French (fr)
Other versions
CA2599712A1 (en
Inventor
Martin Goerne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phrontier Sarl
Original Assignee
Phrontier Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phrontier Sarl filed Critical Phrontier Sarl
Publication of CA2599712A1 publication Critical patent/CA2599712A1/en
Application granted granted Critical
Publication of CA2599712C publication Critical patent/CA2599712C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2599712A 2005-03-01 2006-03-01 Folic acid-, vitamin b6- and vitamin b12-containing agents and the use thereof Expired - Fee Related CA2599712C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005009379A DE102005009379A1 (de) 2005-03-01 2005-03-01 Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung
DE102005009379.5 2005-03-01
PCT/EP2006/001875 WO2006092294A1 (de) 2005-03-01 2006-03-01 Mittel, enthaltend folsäure, vitamin b6 und vitamin b12, und dessen verwendung

Publications (2)

Publication Number Publication Date
CA2599712A1 CA2599712A1 (en) 2006-09-08
CA2599712C true CA2599712C (en) 2014-05-20

Family

ID=36216269

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2599712A Expired - Fee Related CA2599712C (en) 2005-03-01 2006-03-01 Folic acid-, vitamin b6- and vitamin b12-containing agents and the use thereof

Country Status (7)

Country Link
US (1) US8697669B2 (de)
EP (1) EP1853267B9 (de)
CA (1) CA2599712C (de)
DE (1) DE102005009379A1 (de)
ES (1) ES2403679T3 (de)
PL (1) PL1853267T3 (de)
WO (1) WO2006092294A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006032414A1 (de) * 2006-07-13 2008-01-17 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Folsäure, Füllstoffen und Verdickern
DE102006032413A1 (de) * 2006-07-13 2008-01-17 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Folsäure und einem oder mehreren Polyolen
DE102007003795A1 (de) * 2007-01-25 2008-07-31 Phrontier S.A.R.L. Verwendung von Folsäure, Vitamin B6 und Vitamin B12
DE202011109556U1 (de) 2011-10-24 2012-10-29 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Eisenhaltige Vitaminzusammensetzung
EP2674159B1 (de) * 2012-06-15 2016-04-27 Phrontier S.A.R.L. Pharmazeutische Zusammensetzung für die Leber-Regeneration
CN105748503B (zh) * 2016-03-14 2018-10-23 福格森（武汉）生物科技股份有限公司 一种含有5-甲基四氢叶酸的复合维生素微丸
AT15657U1 (de) * 2016-10-06 2018-04-15 Bioenergy Healthcare GmbH Lipidsenker
US11419849B1 (en) 2019-02-06 2022-08-23 Kitt Bio, Inc. Methods and products for adverse effects of air travel, jet lag, or a change to a sleep wake timing cycle

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563126A (en) * 1986-11-20 1996-10-08 Metabolite Laboratories Method for treatment and prevention of deficiencies of vitamins B12, folic acid, and B6
CN1087517A (zh) * 1992-09-14 1994-06-08 韦斯塔药品有限公司 用于降低高半胱氨酸水平的药物制剂
AU5162793A (en) * 1992-09-23 1994-04-12 Kv Pharmaceutical Corporation Multi-vitamin and mineral supplement for pregnant women
US6207651B1 (en) 1996-08-02 2001-03-27 Metabolite Laboratories Method for treatment and prevention of deficiencies of vitamins B12, folic acid, and B6
US5932624A (en) 1995-10-17 1999-08-03 Herbert; Victor D. Vitamin supplement composition
US6129918A (en) 1998-08-13 2000-10-10 Wakunaga Of America Co., Ltd. Method and pharmaceutical composition for reducing serum homocysteine concentration
US6210686B1 (en) * 1998-12-18 2001-04-03 Beth Israel Deaconess Medical Center Dietary supplement and method for lowering risk of heart disease
US6274170B1 (en) 1999-02-18 2001-08-14 Richard Heibel Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same
US6299896B1 (en) 2000-04-13 2001-10-09 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
DE10206159A1 (de) * 2002-02-14 2003-08-28 Kosmas Kg Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung
US20050032740A1 (en) * 2003-08-06 2005-02-10 Balaji Venkataraman Vitamin compositions for the treatment and prevention of vascular disease and dementia
DE102005001479A1 (de) * 2005-01-12 2006-07-20 Synavit Gmbh Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung

Also Published As

Publication number Publication date
US20090054371A1 (en) 2009-02-26
WO2006092294A1 (de) 2006-09-08
PL1853267T3 (pl) 2013-09-30
EP1853267B9 (de) 2013-05-15
DE102005009379A1 (de) 2006-09-07
CA2599712A1 (en) 2006-09-08
EP1853267B1 (de) 2013-01-23
ES2403679T3 (es) 2013-05-21
US8697669B2 (en) 2014-04-15
EP1853267A1 (de) 2007-11-14

Similar Documents

Publication Publication Date Title
CA2599712C (en) Folic acid-, vitamin b6- and vitamin b12-containing agents and the use thereof
US6361800B1 (en) Multi-vitamin and mineral supplement
US6299896B1 (en) Multi-vitamin and mineral supplement
US6245360B1 (en) Nutritional supplement
US6953588B2 (en) Multi-vitamin and mineral supplement
US20050222079A1 (en) Preparation containing folic acid, vitamin b6, and vitamin b12, and use thereof
US20180008634A1 (en) Kits and methods for nutrition supplementation
JP2008509920A (ja) 栄養補充用の組成物及び方法
US6562378B1 (en) Nutritional supplement for adolescents
US6921754B2 (en) Compositions containing folic acid and reduced folate
WO2008079876A1 (en) Methods and kits for co-administration of nutritional supplements
US6565891B1 (en) Nutritional supplement for children
CA2594775C (en) Agents containing folic acid, vitamin b6 and vitamin b12, and the use thereof
US10986857B2 (en) Dietary supplementation with mixed alkali salts
ES2718826T3 (es) Reductor de lípidos
US20200178588A1 (en) Dietary Supplementation with Mixed Alkali Salts
US20180098991A1 (en) Composition for lipid disorder treatment

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20190301